Fresh News; The Farmers' Market Newsletter, Spring 2006

Newsletter produced by Iowa Department of Agriculture and Land Stewardship

Les connectivites: progrès thérapeutiques et place de la biothérapie [Connective tissue diseases: news in therapy, role of biologics agents].

Systemic lupus erythematosus and primary Sjögren's syndrom are the two major connective tissue diseases. A better knowledge of their physiopathology allows us today to propose an adapted therapy. Moreover progress concerns the oldest treatment, hydroxychloroquine, and biotherapy. Hydroxychloroquine is still an actual treatment for lupus, its positive effects are better understood today. Nevertheless it does not seem to be efficient to treat primitive Sjögren. Biotherapy targeting B lymphocytes seems efficient in these two connective tissue diseases. Anti TNF therapy is not recommended and seems to induce connective tissue diseases. The real news is the recent approval and reimbursement in Switzerland of the new drug belimumab (Benlysta) in case of moderate lupus.

ABD e-News December 1, 2006

Weekly Newsletter

ABD e-News December 8, 2006

Weekly Newsletter

ABD e-News December 15, 2006

Weekly Newsletter

ABD e-News December 22, 2006

Weekly Newsletter

ABD e-News December 29, 2006

Weekly Newsletter

ABD e-News January 5, 2007

Weekly Newsletter

ABD e-News January 12, 2007

Weekly Newsletter

ABD e-News January 19, 2007

Weekly Newsletter

ABD e-News January 26, 2007

ABD e-News January 26, 2007

ABD e-News February 2, 2007

Weekly Newsletter

ABD e-News, February 9, 2007

Weekly Newsletter

ABD e-News, February 16, 2007

Weekly Newsletter

Innovative Outstanding Weatherization Assistance News, January, 2006, Vol.4, no.1

This is a quarterly newsletter for the Iowa Weatherization Program. The purpose of the newsletter is to share with you information on all aspects of the program as well as spotlight a couple of agencies in each issue. We will provide information on upcoming events, training schedules, monitoring schedules and general news about the program. There will be a section of questions we have received from you and the answers provided.